| 1 |
28447181 | SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor. | 2017 Apr |
1 |
| 2 |
28598954 | Role of the sympathetic nervous system in regulation of the sodium glucose cotransporter 2. | 2017 Oct |
1 |
| 3 |
28104929 | The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE-/- Mice. | 2016 |
3 |